NEWCASTLE researchers have been awarded a share of $1.8 million in research grants to tackle a disease with one of the lowest survival rates - pancreatic cancer.
University of Newcastle researcher Robert Chapman is developing a non-toxic chemotherapeutic drug without the usual side effects, tweaking a similar drug discovered in the 90s that didn't last long enough in the body to kill cancer cells.
